Arca Biopharma | ABIO - Debt

Arca Biopharma reported $0 in Debt for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Debt Change
Amgen AMGN:US USD 38.94B 241M
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Cytokinetics CYTK:US USD 611.62M 888K
Cytrx CYTR:US USD 0 0
Daiichi Sankyo 4568:JP JPY 143.18B 93M
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Laboratory Of America LH:US USD 5.43B 2.6M
Otsuka Holdings 4578:JP JPY 194.16B 11.4B
United Therapeutics UTHR:US USD 800M 0